In the article titled "Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab" [1] , there were errors, which should be corrected as follows:
(i) In Abstract, the term "(DEP)" should be "(PED)." (ii) In Results, "Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 91 µm, NS; M12: 312 ± 84 µm, NS; M24: 312 ± 12.3, NS)" should be corrected to "Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 14 µm, NS; M12: 313 ± 13.9 µm, NS; M24: 305 ± 76, NS)."
(iii) In Table 2 , there were errors in the values in the third, fourth, and sixth columns. e corrected table and its description are shown below. 
